Jonathan I Friedman
Insider
First SEC filing: Jan. 17, 2017 · Latest: Jan. 17, 2017
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 14, 2017 | XRAY | A | 37 | · | · | 163,546 Direct | +0.02% | Acquired | (price as of 2026-10-02) |
| April 14, 2017 | XRAY | A | 38 | · | · | 163,509 Direct | +0.02% | Acquired | (price as of 2026-10-02) |
| March 22, 2017 | XRAY | A | 574 | $60.85 | $34,928 | 574 Direct | · | Acquired | -85.8% (price as of 2026-10-02) |
| Feb. 22, 2017 | XRAY | A | 3,369 | · | · | 163,471 Direct | +2.10% | Acquired | (price as of 2026-10-02) |
| Feb. 22, 2017 | XRAY | A | 17,400 | · | · | 17,400 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 21, 2017 | XRAY | M | 2,837 | $34.29 | $97,281 | 147,621 Direct | +1.96% | Acquired | -74.7% (price as of 2026-10-02) |
| Feb. 21, 2017 | XRAY | M | 5,580 | $37.26 | $207,911 | 153,201 Direct | +3.78% | Acquired | -76.7% (price as of 2026-10-02) |
| Feb. 21, 2017 | XRAY | M | 6,901 | $47.41 | $327,176 | 160,102 Direct | +4.50% | Acquired | -81.7% (price as of 2026-10-02) |
| Feb. 21, 2017 | XRAY | M | 2,837 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Feb. 21, 2017 | XRAY | M | 5,580 | · | · | 2,790 Direct | -66.67% | Disposed | (price as of 2026-10-02) |
| Feb. 21, 2017 | XRAY | M | 6,901 | · | · | 6,903 Direct | -49.99% | Disposed | (price as of 2026-10-02) |
| Jan. 13, 2017 | XRAY | A | 32 | · | · | 144,784 Direct | +0.02% | Acquired | (price as of 2026-10-02) |
| Nov. 25, 2016 | XRAY | F | 3,370 | $60.75 | $204,728 | 144,752 Direct | -2.28% | Disposed | -85.7% (price as of 2026-10-02) |
| Nov. 20, 2016 | XRAY | F | 474 | $60.16 | $28,516 | 148,122 Direct | -0.32% | Disposed | -85.6% (price as of 2026-10-02) |
| Oct. 14, 2016 | XRAY | A | 47 | · | · | 148,596 Direct | +0.03% | Acquired | (price as of 2026-10-02) |
| July 8, 2016 | XRAY | A | 46 | · | · | 148,549 Direct | +0.03% | Acquired | (price as of 2026-10-02) |
| June 1, 2016 | XRAY | M | 1,376 | $34.29 | $47,183 | 148,503 Direct | +0.94% | Acquired | -74.7% (price as of 2026-10-02) |
| June 1, 2016 | XRAY | M | 1,376 | · | · | 2,837 Direct | -32.66% | Disposed | (price as of 2026-10-02) |
| May 13, 2016 | XRAY | M | 1,458 | $34.29 | $49,995 | 147,127 Direct | +1.00% | Acquired | -74.7% (price as of 2026-10-02) |
| May 13, 2016 | XRAY | M | 1,458 | · | · | 4,213 Direct | -25.71% | Disposed | (price as of 2026-10-02) |
| April 8, 2016 | XRAY | A | 26 | · | · | 26 Direct | · | Acquired | (price as of 2026-10-02) |
| April 8, 2016 | XRAY | A | 23 | · | · | 23 Direct | · | Acquired | (price as of 2026-10-02) |
| March 1, 2016 | XRAY | A | 10,000 | · | · | 10,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 29, 2016 | XRAY | A | 145,669 | · | · | 145,669 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 29, 2016 | XRAY | A | 145,669 | · | · | 145,669 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 29, 2016 | XRAY | A | 5,671 | · | · | 5,671 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 29, 2016 | XRAY | A | 8,370 | · | · | 8,370 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 29, 2016 | XRAY | A | 13,804 | · | · | 13,804 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 22, 2017 | XRAY | Phantom Stock(Supplemental Executive Retirement Plan)(SERP) | Common Stock | · | · | 574 | Acquired |
| Feb. 22, 2017 | XRAY | Stock Option (Right to Buy) | Common Stock | $62.34 | Feb. 22, 2027 | 17,400 | Acquired |
| Feb. 21, 2017 | XRAY | Employee Stock Option (Right to Buy) | Common Stock | $34.29 | Nov. 20, 2022 | 2,837 | Disposed |
| Feb. 21, 2017 | XRAY | Employee Stock Option (Right to Buy) | Common Stock | $37.26 | Nov. 26, 2023 | 5,580 | Disposed |
| Feb. 21, 2017 | XRAY | Employee Stock Option (Right to Buy) | Common Stock | $47.41 | Nov. 25, 2024 | 6,901 | Disposed |
| June 1, 2016 | XRAY | Employee Stock Option (Right to Buy) | Common Stock | $34.29 | Nov. 20, 2022 | 1,376 | Disposed |
| May 13, 2016 | XRAY | Employee Stock Option (Right to Buy) | Common Stock | $34.29 | Nov. 20, 2022 | 1,458 | Disposed |
| April 8, 2016 | XRAY | RSU (Restricted Stock Unit) | Common Stock | · | · | 26 | Acquired |
| April 8, 2016 | XRAY | PSU (Performance Stock Unit) | Common Stock | · | · | 23 | Acquired |
| March 1, 2016 | XRAY | Stock Option | Common Stock | $60.43 | March 1, 2026 | 10,000 | Acquired |
| Feb. 29, 2016 | XRAY | Option (right to buy) | Common Stock | · | Nov. 20, 2022 | 5,671 | Acquired |
| Feb. 29, 2016 | XRAY | Option (right to buy) | Common Stock | · | Nov. 26, 2023 | 8,370 | Acquired |
| Feb. 29, 2016 | XRAY | Option (right to buy) | Common Stock | · | Nov. 25, 2024 | 13,804 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).